Viewing nowSimvastatin Tablets 20 mg (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
Future Bio Pharmaceutical Co., Ltd.

MFDS item code 200402567 · Notified 2004.11.16 · Insurance code 657500690
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular disease
This medication is primarily used to reduce the risk of cardiovascular disease. In particular, it lowers the risk of death associated with coronary events, myocardial infarction, and strokes in high-risk adult patients with a history of coronary artery disease, diabetes, peripheral vascular disease, and stroke. It also helps in the treatment of hyperlipidemia, lowering total cholesterol and LDL cholesterol, while increasing HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia in conjunction with dietary changes. The medication is effective in improving cholesterol levels in pediatric patients with heterozygous familial hypercholesterolemia when diet alone is insufficient. Thus, it is widely used for the prevention of cardiovascular disease and management of hyperlipidemia.
Patients taking this medicine before and during treatment must follow a standard cholesterol-lowering diet. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose of this medicine is 20 mg once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately based on the initial LDL cholesterol level before treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 80 mg dose of this medicine should be used only in patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). 2) See below for recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see 6. Interactions under Precautions for Use). (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is administered concomitantly to patients receiving verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is administered concomitantly to patients receiving amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or concomitantly with a bile acid sequestrant. When this medicine is administered concomitantly with a fibrate (excluding gemfibrozil (see 2. Patients in whom this medicine is contraindicated under Precautions for Use) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Administration to patients with renal impairment Since this medicine is not extensively excreted by the kidneys, no dose adjustment is necessary in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, initiate treatment at 5 mg per day and monitor carefully.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the recommended maximum dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goal. Allow an interval of 4 weeks or longer between dose adjustments.
This medication may cause serious side effects such as myopathy and rhabdomyolysis that can result in muscle abnormalities. The risk is especially heightened when taking a high dose of 80 mg; therefore, caution is required. Patients with known allergies to this drug or its components, those with severe hepatic impairment, and pregnant or nursing women should not take this medication. It is also important to inform the healthcare provider if you are taking other specific medications, as the risk may increase. Individuals with impaired liver or kidney function, as well as those with a history of hypothyroidism or muscle-related diseases, should use this medication with caution. Elderly patients and women are also at a higher risk for muscle abnormalities, necessitating vigilance. Symptoms such as muscle pain, weakness, and tenderness should be reported to healthcare providers immediately, and treatment should be stopped if these symptoms are severe. Regular liver function tests are recommended as liver function abnormalities may occur. This medication can interact with other drugs, so it is essential to disclose any new medications being taken. Women of childbearing potential must use contraception while taking this medication, and if pregnancy is confirmed, the medication should be discontinued immediately. Nursing women are advised to discontinue breastfeeding while on this medication. This drug should not be used in children under 10 years of age or in females before menarche. In case of overdose, standard treatment should be pursued, and the medication should be kept out of reach of children. It is advised not to consume excessive grapefruit juice while taking this medication, as the risk of muscle abnormalities may increase when used with certain medications.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius. Proper storage will help ensure the medication's effectiveness.
Brownish-orange oval film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
Future Bio Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.